Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortizatization of Intangibles Asset Writedowns and Impairment Beginning Cash Balance Capital Expenditures Cash from Discontinued Operations Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Inventory Change in Net Loans Change in Receivables Change in Taxes Depreciation & Amortization (CF)Depreciation and Depletion Divestments Dividends Paid - Common Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other financing activities Sales of Property, Plant and Equipment Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Fortress Biotech (FBIO) Preferred Shares Repurchased (2020)

Fortress Biotech has reported Preferred Shares Repurchased over the past 1 years, most recently at $30000.0 for Q3 2020.